Niagen Bioscience launches drug candidate for rare genetic disease

Go back to Niagen Bioscience launches drug candidate for rare genetic disease
(NASDAQ: NAGE) Delayed: 2.99 --0 (-0%)
Previous Close $2.99    52 Week High
Open $2.99    52 Week Low
Day High $3.03    P/E N/A 
Day Low $2.97    EPS
Volume 609,158